WEI XU
Academic / Other · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Golidocitinib Combined With P-GemOx Plus PD-1 Inhibitor Versus P-GemOx Plus PD-1 Inhibitor in First-Line Newly Extranodal NK/T-cell Lymphoma | Phase 2 | 2026-01-25 |
| Unknown | Penpulimab in Maintenance Therapy in Lymphoma Lymphoma | — | 2023-03-01 |
| Unknown | Robot-assisted Invasion-controlled Surgery Versus Traditional-open Surgery Against Metastatic Spinal Tumor Minimally Invasive Surgery, Spinal Metastases | N/A | 2021-12-25 |
| Unknown | Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary Cancer of Unknown Primary, Bone Cancer Metastatic, Tislelizumab | Phase 2 | 2021-11-12 |
| Completed | Characteristics of Gut Microbiota in Patients With Colon Cancer of Different Traditional Chinese Medicine Synd Colorectal Neoplasms | — | 2019-03-10 |